News

Newly published research shows that Cardiologs' deep learning model can predict the short-term risk of atrial fibrillation (AFib) based on 24-hour Holter recordings that show normal sinus rhythm.

On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its sixth international symposium on complex arrhythmias, EPLive 2022.

Discovery has Potential to Become ‘Powerful Clinical Strategy’ for Treating Heart Disease

Trial will evaluate the safety and effectiveness of AtriCure’s Isolator® Synergy™ Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia.

Introducing more customizable watch faces, an enhanced Workout app, sleep stages, a first-of-its-kind AFib History feature, and an all-new Medications app.

Abbott's Aveir single chamber (VR) pacing system is the world's only leadless pacemaker with a unique mapping capability to assess correct positioning prior to placement

The Company’s development and operational infrastructure will be on track to support anticipated sales growth following commercial rollout on July 1, 2022.

Continued Research into Efficacy of ensoETM for RF Ablation Procedures Will Support Future Regulatory Efforts for Expanded Indications